Advertisement

Topics

Aethlon Medical CEO says 'time is right' to move Aethlon Hemopurifier to human studies

16:14 EDT 18 Oct 2018 | Proactive Investors

Aethlon Medical Inc (NASDAQ:AEMD) CEO Jim Joyce spoke with Proactive Investor's Christine Corrado at the BIO Investor Forum in San Francisco.

The San Diego based company is focused on addressing unmet needs in global health and biodefense with the Aethlon Hemopurifier, a therapeutic device designed for the rapid depletion of circulating viruses and cancer promoting exosomes.

Original Article: Aethlon Medical CEO says 'time is right' to move Aethlon Hemopurifier to human studies

NEXT ARTICLE

More From BioPortfolio on "Aethlon Medical CEO says 'time is right' to move Aethlon Hemopurifier to human studies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...